• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在国家免疫技术咨询小组之间开展高效且可持续的合作:2014年12月8 - 9日于法国巴黎召开的第三届国际技术会议报告

Implementing efficient and sustainable collaboration between National Immunization Technical Advisory Groups: Report on the 3rd International Technical Meeting, Paris, France, 8-9 December 2014.

作者信息

Perronne Christian, Adjagba Alex, Duclos Philippe, Floret Daniel, Houweling Hans, Le Goaster Corinne, Lévy-Brühl Daniel, Meyer François, Senouci Kamel, Wichmann Ole

机构信息

Communicable Diseases Commission, Haut Conseil de la Santé Publique, University of Versailles Saint Quentin, Paris, France.

Health Policy and Institutional Development Unit, WHO Collaborative Centre, at Agence de Médecine Préventive (AMP), Paris, France.

出版信息

Vaccine. 2016 Mar 8;34(11):1325-30. doi: 10.1016/j.vaccine.2016.01.063. Epub 2016 Feb 6.

DOI:10.1016/j.vaccine.2016.01.063
PMID:26859237
Abstract

Many experts on vaccination are convinced that efforts should be made to encourage increased collaboration between National Immunization Technical Advisory Groups on immunization (NITAGs) worldwide. International meetings were held in Berlin, Germany, in 2010 and 2011, to discuss improvement of the methodologies for the development of evidence-based vaccination recommendations, recognizing the need for collaboration and/or sharing of resources in this effort. A third meeting was held in Paris, France, in December 2014, to consider the design of specific practical activities and an organizational structure to enable effective and sustained collaboration. The following conclusions were reached: (i) The proposed collaboration needs a core functional structure and the establishment or strengthening of an international network of NITAGs. (ii) Priority subjects for collaborative work are background information for recommendations, systematic reviews, mathematical models, health economic evaluations and establishment of common frameworks and methodologies for reviewing and grading the evidence. (iii) The programme of collaborative work should begin with participation of a limited number of NITAGs which already have a high level of expertise. The amount of joint work could be increased progressively through practical activities and pragmatic examples. Due to similar priorities and already existing structures, this should be organized at regional or subregional level. For example, in the European Union a project is funded by the European Centre for Disease Prevention and Control (ECDC) with the aim to set up a network for improving data, methodology and resource sharing and thereby supporting NITAGs. Such regional networking activities should be carried out in collaboration with the World Health Organization (WHO). (iv) A global steering committee should be set up to promote international exchange between regional networks and to increase the involvement of less experienced NITAGs. NITAGs already collaborate at the global level via the NITAG Resource Centre, a web-based platform developed by the Health Policy and Institutional Development Unit (WHO Collaborating Centre) of the Agence de Médecine Préventive (AMP-HPID). It would be appropriate to continue facilitating the coordination of this global network through the AMP-HPID NITAG Resource Centre. (v) While sharing work products and experiences, each NITAG would retain responsibility for its own decision-making and country-specific recommendations.

摘要

许多疫苗接种专家坚信,应努力鼓励全球各国免疫技术咨询小组(NITAGs)之间加强合作。2010年和2011年在德国柏林召开了国际会议,讨论改进制定循证疫苗接种建议的方法,认识到在此过程中需要开展合作和/或资源共享。2014年12月在法国巴黎召开了第三次会议,审议具体实践活动的设计以及能够实现有效和持续合作的组织结构。会议达成了以下结论:(i)拟议的合作需要一个核心职能结构,并建立或加强NITAGs国际网络。(ii)合作工作的优先主题包括建议的背景信息、系统评价、数学模型、卫生经济评估以及建立用于审查和分级证据的通用框架和方法。(iii)合作工作计划应从少数已经具备高水平专业知识的NITAGs参与开始。通过实践活动和实际案例,可以逐步增加联合工作的数量。鉴于优先事项相似且已有现有结构,应在区域或次区域层面进行组织。例如,在欧盟,一个由欧洲疾病预防控制中心(ECDC)资助的项目旨在建立一个网络,以改善数据、方法和资源共享,从而支持NITAGs。此类区域网络活动应与世界卫生组织(WHO)合作开展。(iv)应设立一个全球指导委员会,以促进区域网络之间的国际交流,并增加经验较少的NITAGs的参与度。NITAGs已经通过NITAG资源中心在全球层面开展合作,该中心是由预防医学机构(AMP-HPID)的卫生政策与机构发展股(世卫组织合作中心)开发的一个基于网络的平台。通过AMP-HPID NITAG资源中心继续促进这个全球网络的协调是合适的。(v)在分享工作成果和经验的同时,每个NITAG将保留对其自身决策和针对具体国家的建议的责任。

相似文献

1
Implementing efficient and sustainable collaboration between National Immunization Technical Advisory Groups: Report on the 3rd International Technical Meeting, Paris, France, 8-9 December 2014.在国家免疫技术咨询小组之间开展高效且可持续的合作:2014年12月8 - 9日于法国巴黎召开的第三届国际技术会议报告
Vaccine. 2016 Mar 8;34(11):1325-30. doi: 10.1016/j.vaccine.2016.01.063. Epub 2016 Feb 6.
2
Supporting countries in establishing and strengthening NITAGs: lessons learned from 5 years of the SIVAC initiative.支持各国建立和加强国家免疫技术咨询小组:从SIVAC倡议5年中汲取的经验教训。
Vaccine. 2015 Jan 29;33(5):588-95. doi: 10.1016/j.vaccine.2014.12.026. Epub 2014 Dec 26.
3
Strengthening and sustainability of national immunization technical advisory groups (NITAGs) globally: Lessons and recommendations from the founding meeting of the global NITAG network.全球各国免疫技术咨询小组(NITAGs)的强化与可持续性:全球NITAG网络成立会议的经验教训与建议
Vaccine. 2017 May 25;35(23):3007-3011. doi: 10.1016/j.vaccine.2017.04.039. Epub 2017 Apr 26.
4
Moving forward on strengthening and sustaining National Immunization Technical Advisory Groups (NITAGs) globally: Recommendations from the 2nd global NITAG network meeting.推进全球强化和维持国家免疫技术咨询小组(NITAGs):第二届全球 NITAG 网络会议的建议。
Vaccine. 2017 Dec 15;35(50):6925-6930. doi: 10.1016/j.vaccine.2017.10.048. Epub 2017 Nov 2.
5
Value and effectiveness of National Immunization Technical Advisory Groups in low- and middle-income countries: a qualitative study of global and national perspectives.国家免疫技术咨询小组在中低收入国家的价值和效果:全球和国家观点的定性研究。
Health Policy Plan. 2019 May 1;34(4):271-281. doi: 10.1093/heapol/czz027.
6
Progress in the establishment and strengthening of national immunization technical advisory groups: analysis from the 2013 WHO/UNICEF joint reporting form, data for 2012.国家免疫规划技术咨询专家组的建立和加强进展:来自 2013 年世卫组织/联合国儿童基金会联合报告表的分析,数据为 2012 年。
Vaccine. 2013 Nov 4;31(46):5314-20. doi: 10.1016/j.vaccine.2013.08.084. Epub 2013 Sep 20.
7
National Immunization Technical Advisory Groups (NITAGs): guidance for their establishment and strengthening.国家免疫技术咨询专家组(NITAGs):建立和加强其指导原则。
Vaccine. 2010 Apr 19;28 Suppl 1:A18-25. doi: 10.1016/j.vaccine.2010.02.027.
8
The NITAG Resource Centre (NRC): One-stop shop towards a collaborative platform.国家免疫技术咨询小组资源中心(NRC):通向协作平台的一站式服务机构。
Vaccine. 2015 Aug 26;33(36):4365-7. doi: 10.1016/j.vaccine.2015.06.106. Epub 2015 Jul 10.
9
Supporting national immunization technical advisory groups (NITAGs) in resource-constrained settings. New strategies and lessons learned from the Task Force for Global Health's Partnership for influenza vaccine introduction.支持资源有限环境下的国家免疫技术咨询小组(NITAGs)。全球卫生行动专家组在流感疫苗引入方面的新策略和经验教训。
Vaccine. 2019 Jun 19;37(28):3646-3653. doi: 10.1016/j.vaccine.2019.05.046. Epub 2019 May 23.
10
Indicators to assess National Immunization Technical Advisory Groups (NITAGs).评估国家免疫技术咨询小组(NITAG)的指标。
Vaccine. 2013 May 28;31(23):2653-7. doi: 10.1016/j.vaccine.2013.01.047. Epub 2013 Feb 8.

引用本文的文献

1
National decision-making for the introduction of new vaccines: A systematic review, 2010-2020.国家决策引进新疫苗:系统评价,2010-2020 年。
Vaccine. 2021 Apr 1;39(14):1897-1909. doi: 10.1016/j.vaccine.2021.02.059. Epub 2021 Mar 6.
2
Existence and functionality of national immunisation technical advisory groups in Africa from 2010 to 2016.2010 年至 2016 年期间非洲国家免疫技术咨询小组的存在和功能。
Hum Vaccin Immunother. 2018;14(10):2447-2451. doi: 10.1080/21645515.2018.1475815. Epub 2018 Jun 21.
3
Strengthening and sustainability of national immunization technical advisory groups (NITAGs) globally: Lessons and recommendations from the founding meeting of the global NITAG network.
全球各国免疫技术咨询小组(NITAGs)的强化与可持续性:全球NITAG网络成立会议的经验教训与建议
Vaccine. 2017 May 25;35(23):3007-3011. doi: 10.1016/j.vaccine.2017.04.039. Epub 2017 Apr 26.